ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Kenton J. Zehr
Stephen C. Yang
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zehr, K. J.
Right arrow Articles by Heitmiller, R. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zehr, K. J.
Right arrow Articles by Heitmiller, R. F.

Ann Thorac Surg 1998;66:914-919
© 1998 The Society of Thoracic Surgeons


Original articles: General Thoracic

Standardized clinical care pathways for major thoracic cases reduce hospital costs

Kenton J. Zehr, MDa, Patty B. Dawson, RNa, Stephen C. Yang, MDa, Richard F. Heitmiller, MDa

a Division of Thoracic Surgery, The Johns Hopkins Hospital, Baltimore, Maryland, USA

Address reprint requests to Dr Heitmiller, Division of Thoracic Surgery, The Johns Hopkins Hospital, 600 N Wolfe St, Baltimore, MD 21287

Presented at the Forty-fourth Annual Meeting of the Southern Thoracic Surgical Association, Naples, FL, Nov 6–8, 1997.


    Abstract
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 References
 
Background. Standardized clinical care pathways have been developed for postoperative management in an attempt to contain costs in an era of rising health care costs and limited resources. The purpose of this study was to assess the effect of these pathways on length of stay, hospital charges, and outcome for major thoracic surgical procedures.

Methods. All anatomic lung (segmentectomy, lobectomy, and pneumonectomy) and partial and complete esophageal resections performed from July 1991 to July 1997 were retrospectively analyzed for length of stay, hospital charges, and outcome. A prospectively developed database was used. Clinical care pathways were introduced in March 1994. Comparisons were made between the procedures performed before (group I) and after (group II) pathway implementation. Common to both pathways are early mobilization and prudent x-ray and laboratory analysis. In addition, the pathway for esophagectomies emphasizes overnight intubation with 24-hour intensive care unit care, and staged diet advancement. The discharge goal was postoperative day 10. For lung resection the emphasis is early postoperative extubation with overnight intensive care unit management. The discharge goal was postoperative day 7.

Results. Group I esophagectomies (n = 56) had significantly greater hospital charges compared with group II (n = 96) ($21,977 ± $13,555 versus $17,919 ± $5,321; p < 0.04, in actual dollars) and ($29,097 ± $18,586 versus $19,260 ± $6,000; p < 0.001, in dollars adjusted for inflation) and greater length of stay (13.6 ± 6.9 versus 9.5 ± 2.8 days; p < 0.001). Group I lung resections (n = 185) had a significantly greater length of stay compared with group II (n = 241) (8.0 ± 6.2 versus 6.4 ± 3.8 days; p < 0.002); although charges trended downward ($13,113 ± $10,711 versus $12,404 ± $7,189; not significant) in actual dollars, charges were significantly less in dollars adjusted for inflation ($17,103 ± $13,211 versus $13,432 ± $8,056; p < 0.01). The most significant decreases in charges for esophagectomies were in miscellaneous charges (61% in dollars adjusted for inflation), pharmaceuticals (60%), laboratory (42%) and radiologic (39%) tests, physical therapy charges (35%), and routine charges (34%). For lung resections the greatest savings occurred for pharmaceuticals (38%), supplies (34%), miscellaneous charges (25%), and routine charges (22%). Mortality was similar (esophagectomies: I, 3.6%; II, 0%; lung resections: I, 0.5%; II, 0.8%; not significant).

Conclusions. Introduction of standardized clinical pathways has resulted in a marked reduction of length of stay for all major thoracic surgical procedures. Total charges were reduced for both esophagectomies (34%) and lung resections (21%) with continued quality of outcome.


    Introduction
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 References
 
Consistency in providing patient care is an effective way of improving quality. Physician-directed diagnostic and therapeutic plans have been shown to be crucial in this process [1]. Clinical care pathways have been developed for a wide variety of disease processes requiring medical and surgical intervention [27]. Pathway implementation has been shown to reduce hospital length of stay (LOS) and significantly reduce diagnostic testing. The ability of the caregivers and the patients and their families to have clear expectations has decreased the need for defensive medicine [8]. Whether these quality of care benefits translate to costs savings in an era of rising health care costs and limited resources is less clear. We sought to assess the effect of these pathways on hospital charges, LOS, and outcome for major thoracic surgical procedures.


    Material and methods
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 References
 
All anatomic lung (segmentectomy, lobectomy, and pneumonectomy) and partial and complete esophageal resections performed from July 1991 to July 1997 were retrospectively analyzed for LOS, hospital charges, and outcome. A prospectively developed database was used. Clinical care pathways were introduced in March 1994. Comparisons were made between the procedures performed before (group I) and after (group II) pathway implementation. Charges were categorized and compared by routine charges, operating room charges, pharmaceuticals, radiologic tests, laboratory tests, supplies, physical therapy charges, and miscellaneous charges. All data presented are presented as charges.

The esophagectomy clinical pathway emphasizes overnight intubation and 24- to 36-hour intensive care unit care. Patients are on telemetry, and vital signs and hemodynamics are continuously monitored, including blood pressure, central venous pressure, pulmonary artery pressure and cardiac output in selected patients, O2 saturation, and end-tidal CO2. Analgesia is patient controlled by means of an epidural catheter or intravenously. On postoperative day (POD) 2, monitoring lines, neck drain, and Foley catheter are discontinued and the patients are transferred to the ward. On POD 3, enteral tube feedings are begun at 10 mL/h and advanced to 30 mL/h over 2 days. Supplemental O2 is weaned and physical therapy is initiated. If a chest tube is used it is removed on POD 4. On POD 5 or 6 a video esophagogram is performed, and a four-stage esophageal diet is commenced. The discharge goal is POD 10. Perioperative antibiotics are continued for 24 hours. Medications throughout postoperative course include H2 histamine blockers and analgesics; simethicone and stool softener are started on POD 6. Laboratory tests are performed on PODs 1, 2, and 4.

The thoracotomy clinical pathway emphasizes operating room extubation and 12- to 24-hour intensive care unit care. Patients are on telemetry and their vital signs continuously monitored. Postoperative analgesia is patient controlled by means of an epidural catheter or intravenously. A postoperative chest film is obtained. Thereafter, one chest film per day is obtained until the chest drains are discontinued on POD 3 or 4. On POD 1 the patient is transferred to the ward. Oral intake is commenced. Supplemental O2 is weaned. Laboratory testing is performed on POD 1, and only if necessary thereafter. Early mobilization is stressed beginning the night of the operation. Perioperative antibiotics are continued for 24 hours. Medications throughout postoperative course include H2 histamine blockers and analgesics. Inhalation agents are used as needed. The goal for discharge is POD 6.

Adjustment for constant charge dollars was made using the approved Maryland Health Services Cost Review Commission methodology (Table 1). This methodology adjusts charges annually by an approved price increase. The Health Services Cost Review Commission rate year is October 1 to September 30. The number was then converted to the fiscal year at The Johns Hopkins Hospital, July 1 to June 30. The charge increases were compounded yearly. Statistical analysis comparing hospital charges, LOS, and mortality rates was performed using the two-tailed Student’s t test. Significance was accorded to p values of less than 0.05.


View this table:
[in this window]
[in a new window]
 
Table 1. Conversion Rate to Constant Charge Dollars Adjusted by Yearly Price Increase

 
The comparison of costs to charges has been relatively constant between fiscal years 1992 and 1997 (1992, 77%; 1993, 73%; 1994, 73%; 1995, 75%; 1996%, 77%; and 1997, 85%). For example, in 1992, .


    Results
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 References
 
Group I esophagectomies (n = 56) were admitted to The Johns Hopkins Hospital between July 1991 and March 1994 and group II (n = 96) between April 1994 and July 1997. Ages were similar (group I, 59.5 ± 11.6 years versus group II, 57.4 ± 13.5 years). Groups I (n = 185) and II (n = 241) lung resection corresponded to similar dates. Ages were not significantly different (group I, 61.8 ± 11.7 years versus group II, 63.7 ± 11.5 years). Procedures performed are categorized in Table 2.


View this table:
[in this window]
[in a new window]
 
Table 2. Procedures Performed

 
Group I esophagectomies (n = 56) had significantly greater hospital charges compared with group II (n = 96) ($21,977 ± $13,555 versus $17,919 ± $5,321; p < 0.04, in actual dollars) and ($29,097 ± $18,586 versus $19,260 ± $6,000; p < 0.001, in dollars adjusted for inflation) (Fig 1). Overall percent decrease was 18% in actual dollars and 34% in dollars adjusted for inflation. This translates to a savings of $389,568 and $944,352, respectively, since implementation of pathway management. Significant decreases in charges were realized in most categories (Fig 2); miscellaneous charges (61% decrease in dollars adjusted for inflation), pharmaceuticals (60%), laboratory (42%) and radiologic (39%) tests, physical therapy charges (35%), and routine charges (34%). Charges of supplies and operating room charges were not greatly affected. When charges for esophagectomies were analyzed by year there was a continuous decrease in charge from 1991 to 1997 ($24,806 ± $13,663 to $16,219 ± $3,242 in actual dollars; $35,224 ± $19,401 to $16,219 ± $3,242 in dollars adjusted for inflation) (Fig 3).



View larger version (23K):
[in this window]
[in a new window]
 
Fig 1. Total hospital charges for esophagectomy patients, in actual dollars and constant dollars adjusted for inflation according to Table 1.

 


View larger version (31K):
[in this window]
[in a new window]
 
Fig 2. Categorized hospital charges for esophagectomy patients in actual dollars (A) and in constant dollars adjusted for inflation (B). (lab = laboratory charges; OR = operating room charges; other = miscellaneous charges; pharm = pharmaceutical charges; PT = physical therapy charges; rad = radiology charges; supp = supplies.)

 


View larger version (23K):
[in this window]
[in a new window]
 
Fig 3. Decreasing charges of esophagectomy patients year by year, in actual and constant dollars adjusted for inflation according to Table 1.

 
Charges for group I lung resections (n = 185) charges trended downward compared with group II (n = 241) ($13,113 ± $10,711 versus $12,404 ± $7,189; not significant) in actual dollars; charges were significantly less in dollars adjusted for inflation ($17,103 ± $13,211 versus $13,432 ± $8,056; p < 0.01) (Fig 4). This represents a savings of $170,628 in actual dollars and $854,029 in dollars adjusted for inflation. The overall percent decrease in charges was 5.4% in actual dollars and 21% in dollars adjusted for inflation. The greatest savings (Fig 5) occurred in pharmaceuticals (38% decrease in dollars adjusted for inflation), supplies (34%), miscellaneous charges (25%), and routine charges (22%). Similarly, operating room charges were unaffected by pathway implementation. There were minimal savings in the radiology and laboratory charges. When charges for lung resections were categorized by year there was a continuous decrease in charge from 1991 to 1997 ($14,553 ± $13,121 to $11,980 ± $4,904 in actual dollars; $20,665 ± $18,631 to $11,980 ± $4,904 in dollars adjusted for inflation) (Fig 6).



View larger version (15K):
[in this window]
[in a new window]
 
Fig 4. Total hospital charges for anatomic lung resection patients, in actual dollars and constant dollars adjusted for inflation according to Table 1.

 


View larger version (29K):
[in this window]
[in a new window]
 
Fig 5. Categorized hospital charges for anatomic lung resection patients in actual dollars (A) and in constant dollars adjusted for inflation (B). (lab = laboratory charges; OR = operating room charges; other = miscellaneous charges; pharm = pharmaceutical charges; PT = physical therapy charges; rad = radiology charges; supp = supplies.)

 


View larger version (16K):
[in this window]
[in a new window]
 
Fig 6. Decreasing charges of anatomic lung resection patients year by year, in actual and constant dollars adjusted for inflation according to Table 1.

 
Length of stay was a significant factor in charge reduction. Group I esophagectomies had greater LOS (13.6 ± 6.9 versus 9.5 ± 2.8 days; p < 0.001). Preoperative days were reduced from 1.1 ± 2.9 to 0.2 ± 1.0 days (p < 0.01) and postoperative stay decreased from 12.5 ± 5.7 to 9.2 ± 2.9 days (p < 0.001). Because routine charges was the most costly category, this reduction represented 44% of the total savings. Group I lung resections had a significantly greater LOS compared with group II (8.0 ± 6.2 versus 6.4 ± 3.8 days; p < 0.002). Preoperative stay was similar; group I had 0.37 ± 1.84 days and group II 0.22 ± 1.5 days (not significant). However, postoperative LOS was reduced from 7.6 ± 5.6 to 6.1 ± 3.4 days (p < 0.01). As a result, 40% of the overall savings was realized in this category. When LOS was analyzed by year, there was an initial dramatic decline during the piloting period of the clinical pathways in 1992 and 1993 to a relative plateau with a marked decrease in standard deviation since pathway implementation (Fig 7).



View larger version (23K):
[in this window]
[in a new window]
 
Fig 7. Decreasing length of stay in both esophagectomy and anatomic lung resection patients year by year.

 
Mortality was similar (esophagectomies: I, 3.6%; II, 0%; lung resections: I, 0.5%; II, 0.8%; not significant).


    Comment
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 References
 
Clinical care pathways, formally known as physician-directed diagnostic and therapeutic plans [1], were developed to standardize postoperative patient care. The primary impetus to develop clinical pathways was to improve quality of care. However, in this day of rising hospital costs and capitation, there has also been tremendous pressure to reduce costs while maintaining quality [9]. Clinical care pathways have been embraced as a means to accomplish both goals. The earliest applications of clinical pathways to patients undergoing joint replacement and treatment for congestive heart failure realized a significant reproducible reduction in hospital charges while improving quality [2]. Further applications of this methodology have been shown to address both concerns in areas specific to cardiothoracic surgery; coronary artery bypass surgery [5], thoracoscopic procedures [3], congenital heart surgery [7], and pulmonary lobectomies [4].

Creation and maintenance of thoracic surgical pathways at The Johns Hopkins Hospital has been a dynamic process. There were two goals set for pathway development and for ongoing adjustments. The first goal was to find out what tests and interventions were necessary to treat the ideal patient undergoing routine esophageal and anatomic lung resections. Standardizing postoperative care with deletion of superfluous tests would explain the observed initial decrease in cost of care. The second goal was to identify limiting factors in postoperative care that largely dictate length of hospital stay for a given operative procedure, and to see what could be done to optimally manage these factors. This process would explain the observed continued decrease in costs. Our premise has been that many of the benchmarks for surgical care of the patient with esophageal or lung cancer are based on historic clinical practice guidelines that have been passed down, often unchallenged, through an apprenticeship training program. Challenging these guidelines through interval meetings and dynamic modification of the pathway has been a hallmark of our system. For lung resections, factors that limit LOS include pain control, air leaks, supplemental oxygen requirement, and respiratory care. For esophagectomies, factors that limit LOS include pain control, respiratory care, anastomotic healing, and subsequent oral alimentation. Therefore, measures to improve postoperative pain control and respiratory care, techniques to reduce lung air leaks, better insight into the process of anastomotic healing, all would be expected to reduce LOS without compromising safety of care. Our data suggest the ongoing dynamic nature of the pathway and its effect on charges. In Figures 3 and 6 the charges per year show a continuous decline both in actual dollars and dollars adjusted for inflation. Although the most rapid decreases occurred in the early 90s during the time when cost containment began to be a priority, ongoing cost reduction has occurred because of changes resulting from feedback from pathway caregivers.

Pathways are particularly applicable to surgical services in large teaching hospitals where there is a steady stream of residents and fellows taking care of patients postoperatively. In these systems there is tremendous variability in what tests the caregiver believes needs to be obtained to manage the patient appropriately. Most of the interventions and tests thought necessary by caregivers are directly controlled by physicians but are categorized as laboratory, radiologic, pharmaceutical, and operating room charges. Indirectly, routine charges are under physician control, being profoundly influenced by LOS. At the New York Hospital–Cornell Medical Center, 70% of the total cost in the hospital was found to be physician controlled [10]. Loop [11] emphasizes the physician as the utilization manager in an era when hospital costs are increasing at 8% annually and reimbursements have failed to increase accordingly. Our physician-directed clinical pathway methodology addressed cost containment in all areas. The reduction in variability of charges is evidenced by the decrease in standard deviation in all categories since introduction of pathways (Figs 2, 5). Residents and fellows learn a consistent pattern of care as opposed to a trial and error approach repeated on a monthly basis as they rotate on the service.

The reduced LOS was the most significant factor in charge reduction. This is manifested in the routine charge category. Forty-four percent and 40% of the total charge reduction was realized in routine charges in esophogectomies and lung resections, respectively. Several changes were responsible for these savings. Esophagectomy patients are now admitted on the same day as the operation. The bowel preparation is done as an outpatient procedure. Several days of hospital stay of the esophagectomy patients have been reduced postoperatively by acceleration of diet advancement. In the lung resection patients postoperative LOS has been reduced by earlier discontinuation of chest tubes. The preoperative days had been eliminated before clinical pathway introduction. This was partially responsible for the decreased charges realized in 1992 and 1993 seen in Figure 6. Indirectly, improved pain management and its associated improved pulmonary function and earlier self-sufficiency has readied patients for earlier discharge. When evaluated by the year, LOS had a parallel downward trend compared with charges in both categories (Fig 7). Again, the standarization of care is evident with a marked decrease in the standard deviation in LOS since 1994.

There were several areas that were not as clearly affected by clinical pathway management: operating room charges, supplies, and physical therapy charges for esophagectomy patients; and operating room charges, radiologic and laboratory charges, and physical therapy charges for lung resection patients. Operating room charges, supply charges, and physical therapy charges were not under the influence of the physicians directing care of the thoracic patient. Charges occurring in these areas have been determined by personnel in charge of operating room supplies and the physical therapy division. These are areas that are currently being targeted for cost reduction in pathway meetings. With regards to radiologic and laboratory charges in the lung resection patients, significant reduction in utilization of these resources took place in the 2 years before official clinical pathway introduction. They had already nearly approached their limit of appropriate utilization.

Mortality has remained unaffected by these substantial changes in clinical practice. There have been no deaths in esophagectomy patients since introduction of clinical pathways and 0.8% or 2 patient deaths in the lung resection group. This maintenance of quality has been demonstrated in other similar series managed by clinical pathways [35, 7].

This study presents clinical pathway methodology as a dynamic process that has been effective in producing significant cost reduction for major thoracic surgical procedures. Total charges were reduced for both esophagectomies (18% in actual dollars, 34% in dollars adjusted for inflation) and lung resections (5.4%, 21%) with continued quality of outcome.


    References
 Top
 Abstract
 Introduction
 Material and methods
 Results
 Comment
 References
 

  1. Hart R.I., Musfeldt C.M. MD-directed critical pathways: it’s time. Hospitals 1992;66:56.[Medline]
  2. Musfeldt C., Hart R.I. Physician-directed diagnostic and therapeutic plans: a quality cure for America’s health-care crisis. J Soc Health Syst 1993;4:80-88.[Medline]
  3. Patton M.D., Scaerf R. Thoracotomy, critical pathway, and clinical outcomes. Cancer Pract 1995;3:286-294.[Medline]
  4. Wright C.D., Wain J.C., Grillo H.C., Moncure A.C., Macaluso S.M., Mathisen D.J. Pulmonary lobectomy patient care pathway: a model to control cost and maintain quality. Ann Thorac Surg 1997;6:299-302.
  5. Velasco F.T., Ko W., Rosengart T., et al. Cost containment in cardiac surgery: results with a critical pathway for coronary bypass surgery at the New York Hospital–Cornell Medical Center. Best Pract Benchmarking Healthcare 1996;1:21-28.
  6. Cohen J., Stock M., Anderson P., Everts E. Critical pathways for head and neck surgery. Development and implementation. Arch Otolaryngol Head Neck Surg 1997;123:11-14.[Abstract/Free Full Text]
  7. Turley K., Tyndall M., Roge C., et al. Critical pathway methodology: effectiveness in congenital heart surgery. Ann Thorac Surg 1994;58:57-63.[Abstract]
  8. Shulkin D.J., Ferniany I.W. The effect of developing patient compendiums for critical pathways on patient satisfaction. Am J Med Qual 1996;11:43-45.
  9. Denton T.A., Chaux A., Matloff J.M. A cardiothoracic surgery information system for the next century: implications for managed care. Ann Thorac Surg 1995;59:486-493.[Abstract/Free Full Text]
  10. Skinner D.B. Are cost considerations contradictory to quality?. Ann Thorac Surg 1995;60:1498-1499.[Free Full Text]
  11. Loop F.D. You are in charge of cost. Ann Thorac Surg 1995;60:1509-1512.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
E. S. Weiss, J. G. Allen, R. A. Meguid, N. D. Patel, C. A. Merlo, J. B. Orens, W. A. Baumgartner, J. V. Conte, and A. S. Shah
The impact of center volume on survival in lung transplantation: an analysis of more than 10,000 cases.
Ann. Thorac. Surg., October 1, 2009; 88(4): 1062 - 1070.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. S. Bryant and R. J. Cerfolio
The analysis of a prospective surgical database improves postoperative fast-tracking algorithms after pulmonary resection.
J. Thorac. Cardiovasc. Surg., May 1, 2009; 137(5): 1173 - 1179.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
G. Varela, M. F. Jimenez, N. M. Novoa, and J. L. Aranda
Postoperative chest tube management: measuring air leak using an electronic device decreases variability in the clinical practice
Eur. J. Cardiothorac. Surg., January 1, 2009; 35(1): 28 - 31.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. A. Meguid, E. S. Weiss, D. C. Chang, M. V. Brock, and S. C. Yang
The effect of volume on esophageal cancer resections: what constitutes acceptable resection volumes for centers of excellence?
J. Thorac. Cardiovasc. Surg., January 1, 2009; 137(1): 23 - 29.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
D. J. Zand, K. M. Brown, U. Lichter-Konecki, J. K. Campbell, V. Salehi, and J. M. Chamberlain
Effectiveness of a Clinical Pathway for the Emergency Treatment of Patients With Inborn Errors of Metabolism
Pediatrics, December 1, 2008; 122(6): 1191 - 1195.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. S. Weiss, R. A. Meguid, N. D. Patel, S. D. Russell, A. S. Shah, W. A. Baumgartner, and J. V. Conte
Increased Mortality at Low-Volume Orthotopic Heart Transplantation Centers: Should Current Standards Change?
Ann. Thorac. Surg., October 1, 2008; 86(4): 1250 - 1260.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. A. Meguid, B. S. Brooke, D. C. Chang, J. T. Sherwood, M. V. Brock, and S. C. Yang
Are Surgical Outcomes for Lung Cancer Resections Improved at Teaching Hospitals?
Ann. Thorac. Surg., March 1, 2008; 85(3): 1015 - 1025.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. J. McKenna Jr, A. Mahtabifard, A. Pickens, D. Kusuanco, and C. B. Fuller
Fast-Tracking After Video-Assisted Thoracoscopic Surgery Lobectomy, Segmentectomy, and Pneumonectomy
Ann. Thorac. Surg., November 1, 2007; 84(5): 1663 - 1668.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
A. E. Martin-Ucar, E. Passera, R. Vaughan, and G. Rocco
Implementation of a user-friendly protocol for interpretation of air-leaks and management of intercostal chest drains after thoracic surgery
Interactive CardioVascular and Thoracic Surgery, September 1, 2003; 2(3): 251 - 255.
[Abstract] [Full Text] [PDF]


Home page
Am J Crit CareHome page
J. M. Welton, A. A. Meyer, L. Mandelkehr, S. M. Fakhry, and S. Jarr
Outcomes of and Resource Consumption by High-Cost Patients in the Intensive Care Unit
Am. J. Crit. Care., September 1, 2002; 11(5): 467 - 473.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. B. Dimick, S. M. Cattaneo, P. A. Lipsett, P. J. Pronovost, and R. F. Heitmiller
Hospital volume is related to clinical and economic outcomes of esophageal resection in Maryland
Ann. Thorac. Surg., August 1, 2001; 72(2): 334 - 340.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. J. Cerfolio, A. Pickens, C. Bass, and C. Katholi
Fast-tracking pulmonary resections
J. Thorac. Cardiovasc. Surg., August 1, 2001; 122(2): 318 - 324.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
V. Von Dossow, M. Welte, U. Zaune, E. Martin, M. Walter, J. Ruckert, W. J. Kox, and C. D. Spies
Thoracic Epidural Anesthesia Combined with General Anesthesia: The Preferred Anesthetic Technique for Thoracic Surgery
Anesth. Analg., April 1, 2001; 92(4): 848 - 854.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. R. Every, J. Hochman, R. Becker, S. Kopecky, and C. P. Cannon
Critical Pathways : A Review
Circulation, February 1, 2000; 101(4): 461 - 465.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Kenton J. Zehr
Stephen C. Yang
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zehr, K. J.
Right arrow Articles by Heitmiller, R. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zehr, K. J.
Right arrow Articles by Heitmiller, R. F.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS